In win for generics industry, Viatris wards off $50M payment in tax battle with IRS fkansteiner Mon, 07/31/2023 – 14:32 More: In win for generics industry, Viatris wards off M payment in tax battle with IRS Source: fierce
read moreGSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer aliu Mon, 07/31/2023 – 14:14 More: GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer Source: fierce
read moreJohnson & Johnson’s $8.9B talc deal in jeopardy as judge shoots down 2nd bankruptcy attempt zbecker Mon, 07/31/2023 – 10:55 More: Johnson & Johnson's .9B talc deal in jeopardy as judge shoots down 2nd bankruptcy attempt Source: fierce
read moreNimble Works launches sister healthcare tech agency with GE HealthCare, Clario already signed up badams Mon, 07/31/2023 – 10:24 More: Nimble Works launches sister healthcare tech agency with GE HealthCare, Clario already signed up Source: fierce
read moreCitius’ $40M bid to market a follow-up to Eisai’s Ontak hits wall at FDA fkansteiner Mon, 07/31/2023 – 09:49 More: Citius' M bid to market a follow-up to Eisai's Ontak hits wall at FDA Source: fierce
read moreNovel therapy, OK-101, offers a potential way of relieving neuropathic corneal pain More: Okyo reaches clinical trial agreement with Tufts Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals